Brais Lauren K - ‖ Department of Medical Oncology, Dana-Farber Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 205 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Figure 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 3 from ras/raf Comutation and erbb2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

Harshabad Singh,Pranshu Sahgal,Kevin S. Kapner,Steven M. Corsello, Hersh Gupta,Rahul Gujrathi,Yvonne Li, Andrew D. Cherniack,Raquelle El Alam,Joseph Kerfoot,Elizabeth Andrews, Annette Lee,Chetan Nambiar,Alison M. Hannigan,Joshua Remland,Lauren K. Brais,Meghan E. Leahy, Douglas A. Rubinson,Benjamin L. Schlechter, Matthew Meyerson,Yanan Kuang, Cloud P. Paweletz, Jessica Lee,Júlia C.F. Quintanilha, Andrew J. Aguirre,Kimberly Perez,Brandon M. Huffman,Humberto Rossi, Thomas A. Abrams,Sheheryar Kabraji,Livio Trusolino,Andrea Bertotti,Ewa T. Sicinska, Aparna R. Parikh, Brian M. Wolpin, Alexa B. Schrock, Marios Giannakis, Kimmie Ng,Jeffrey A. Meyerhardt,Jason L. Hornick,Nilay S. Sethi, James M. Cleary

openalex

Cited0Views0Bibtex

Supplementary Table 9 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Epigenetic and oncogenic inhibitors cooperatively drive differentiation and kill KRAS-mutant colorectal cancers

Patrick Loi,Amy E Schade,Carrie L Rodriguez, Anjana Krishnan,Naiara Perurena, Van T M Nguyen, Yilin Xu,Marina Watanabe,Rachel A Davis,Alycia Gardner,Natalie F Pilla,Kaia Mattioli,Olesja Popow,Nuray Gunduz,Tamsin R M Lannagan, Samantha Fitzgerald,Ewa T Sicinska,Jia-Ren Lin, William Tan,Lauren K Brais,Kevin M Haigis,Marios Giannakis,Kimmie Ng,Sandro Santagata,Kristian Helin, Owen J Sansom, Karen Cichowski

Cancer discovery (2024)

Cited0Views0WOSBibtex

Supplementary Table 2 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Methods 1 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 3 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 6 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 6 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn